CDX 7.02% 6.1¢ cardiex limited

Ann: CardieX Limited Appendix 4D and Half Year Report, page-43

  1. 2,287 Posts.
    lightbulb Created with Sketch. 2792
    Yes, it is the ATCOR Pulse :

    Our launch date for the Pulse remains on track and we’ve already received the first prototypes and test
    units in our US and Sydney offices. Our first contracted order of the Pulse will be ~10,000 units. As a
    guide to the impact of this new device on the revenues for the Company, our current device sales of
    the XCEL central blood pressure monitor (which constitutes the most significant portion of our sales)
    are in the low hundreds annually


    A reminder from the ASX release about Andon and Atcor Pulse :

    The first device under the Agreement to be named ATCOR “Pulse” (the Device) and will be
    targeted for commercial launch in the US, Europe, Australia and China in Q4 2021.

    ATCOR “Pulse” will be the first new medical device for ATCOR since 2012 and represents a
    game changing medical technology collaboration for home-use vital signs monitoring. This
    unique device will be the world’s first cloud-connected home-use BP monitor to include
    ATCOR’s SphygmoCor® technology and Arty™, ATCOR’s new cardiovascular vital signs and
    telehealth platform (Arty™ being an anagram of “Heart” and “Artery”).

    The Agreement with Andon in conjunction with the ATCOR “Pulse” device significantly
    expands the commercial market opportunity for CardieX into the home consumer health
    device market, which is estimated to be worth $US2.5B annually (Source: Fortune Business
    Insight).

    When paired with ATCOR’s Arty™ app, the Device will provide full remote patient monitoring
    of a patient’s vital signs at home. The remote patient monitoring market is estimated to
    reach $US43B by 2027 (Source: 2020 Research & Markets Report).

    At launch, the device and will also be fully telehealth-enabled with video, chat, messaging,
    customizable screens and full vital signs sharing features between clinician and patient when
    paired with the Company’s Arty™ app. ATCOR Pulse will be the first blood pressure device
    ever to feature customizable screens and vital signs modules when integrated with the
    Company’s new Arty™ app.


 
watchlist Created with Sketch. Add CDX (ASX) to my watchlist
(20min delay)
Last
6.1¢
Change
0.004(7.02%)
Mkt cap ! $17.94M
Open High Low Value Volume
5.8¢ 6.1¢ 5.8¢ $15.92K 266.7K

Buyers (Bids)

No. Vol. Price($)
1 35000 5.7¢
 

Sellers (Offers)

Price($) Vol. No.
6.1¢ 50000 1
View Market Depth
Last trade - 15.53pm 16/08/2024 (20 minute delay) ?
CDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.